Background: Factors affecting heart rate variability (HRV) in patients with atrial septal defect (ASD) have not been clarified. This study sought to identify those factors and establish a preliminary risk model. Methods: A total of 154 patients with ASD who underwent transcatheter closure and met the study requirements were analyzed in this study. Moreover, 26 patients with patent foramen ovale (PFO) were enrolled in our study as a control group. All patients underwent echocardiography and ambulatory electrocardiography before and one day after the procedure. Results: The standard deviation of all normal-to-normal (NN) intervals (SDNN) and the standard deviation of the averages of the NN intervals in all 5 min segments of the entire recording (SDANN) were significantly higher and the heart rate was lower after closure than before closure in patients with ASD (SDNN: 6.08, 95% CI 3.00 to 9.15, p < 0.001; SDANN: 7.57, 95% CI 4.50 to 10.64, p < 0.001; heart rate: -1.17, 95% CI − 2.86 to − 0.48, p = 0.006). Multiple regression analyses indicated that age, sex, defect diameter, heart rate and diabetes were significantly associated with HRV indices (SDNN: R2 = 0.415; P < 0.001). SDNN and SDANN had obvious correlations with right ventricular systolic pressure (SDNN: R = − 0.370, p < 0.001; SDANN: R = − 0.360, p < 0.001). Conclusions: Factors affecting HRV in patients with ASD include age, sex, heart rate, defect size and diabetes. Furthermore, right ventricular systolic pressure plays an important role in the change in HRV.
11 July 2023 in Frontiers in Cardiovascular Medicine
Objective: To compare the recent efficacy and safety of different Amplatzer models and similar occluder in the treatment of patent foramen ovale (PFO).Methods: Patients with PFO complicated with cryptogenic stroke or migraine who underwent transcatheter closure of PFO in the First Affiliated Hospital of Nanjing Medical University from September 2019 to March 2021 were selected. Patients were grouped according to the type of occluder device. The basic data of the patients were collected and followed up within 1 year after occlusion. Effectiveness was defined as no recurrence of stroke/remission of migraine symptoms and a negative postoperative foaming test, and safety events were counted as the combined results of serious adverse events.Results: A total of 92 patients were selected, including 45 cases in the symmetrical group and 47 cases in the asymmetric group. There were no serious adverse events in the 2 groups during follow-up. 3 days and 1 month after occlusion, the number of shunt patients in the asymmetric group was significantly less than that in the symmetric group (χ2 = 5.484, P = 0.019; χ2 = 5.146, P = 0.023). The negative rate of blocked residual shunts in the asymmetric group was higher than that in the symmetric group at 1, 3, 6 and 12 months after occlusion (χ2 = 6.473, P = 0.011; χ2 = 4.305, P = 0.038; χ2 = 4.842, P = 0.027; χ2 = 4.034, P = 0.045). Headache in migraine patients in the asymmetric group was significantly better than headache in patients in the symmetric group (P = 0.038; P = 0.049).Conclusion: Asymmetric Amplatzer and similar occluders provide greater efficacy in short-term occlusion than symmetric ones.
Transcatheter aortic valve replacement (TAVR) has advanced from an emerging technology to a standard therapeutic option for high-risk patients with symptomatic severe aortic stenosis (AS). Procedural risk correlates strongly with aortic root anatomy. In elderly patients with bicuspid aortic valves, concomitant horizontal cardiac orientation and ascending aortic dilation confer markedly higher procedural risk. We report an elderly patient with a bicuspid aortic valve, severe horizontal aortic root angulation (88°), and ascending aortic dilation (approximately 60 mm). The presence of an ascending aortic aneurysm supported the indication for surgical intervention.Given the substantial technical complexity and perioperative risk of open-heart surgery, TAVR was selected as a safer alternative. This case demonstrates that TAVR remains feasible in elderly patients with complex anatomy unsuitable for surgery, despite increased procedural challenges and risk. In elderly patients with severe AS and anatomically complex aortic pathology, TAVR should be considered a clinically viable treatment strategy.
21 April 2026 in European Heart Journal - Case Reports
Background: Left posterior fascicular ventricular tachycardia (LPF-VT) is considered the most common type of fascicular ventricular tachycardia. False tendons (FTs) are reported to be common in patients with LPF-VT and may contribute to the pathogenesis of this condition. However, LPF-VT cases with congenital septal structural abnormalities have not been reported. Case summary: This case report investigated an 86-year-old woman diagnosed with LPF-VT who underwent radiofrequency ablation. The preoperative transthoracic echocardiography (TTE) results indicated no anatomic abnormalities. During the procedure, the intracardiac echocardiography (ICE) revealed a fissure within the ventricular septum. The successful ablation site was precisely located at the left orifice of this fissure. To improve treatment efficacy, the catheter was advanced into the fissure to continue ablation. One month postoperatively, the patient presented with mild shortness of breath after activity. The TTE revealed a 15× 16-mm iatrogenic ventricular septal defect (VSD) with a pulmonary artery pressure (PAP) of 48 mmHg. Percutaneous VSD closure resolved the symptoms, and the PAP returned to normal. During the follow-up period, no recurrence of palpitations or dyspnoea was observed. Discussion: Macro-re-entry has been suggested as the mechanism of LPF-VT, as FTs can provide an electro-anatomical substrate for LPF-VT. In the present case, the re-entrant circuit of LPF-VT may be associated with the rare anatomic anomaly, although a definitive link remains unestablished. Additionally, extreme caution should be exercised during catheter manipulation to prevent iatrogenic injuries.